The turnover of Carl Zeiss Meditec increased from 10 million euros to 70 million euros in the first quarter of the 2022/2023 financial year. Significantly shrinking margins, however, reduced the quarterly result before interest and taxes from 7 . million euros to 60.3 million euros. „In a challenging environment with continued tight supply chains and constraints in the important Chinese market, we were still able to achieve further growth. Our team is working decisively to shorten delivery times for customers. At the same time, we are constantly investing in our future growth,” says Markus Weber, CEO of Carl Zeiss Meditec AG in Jena for the financial year of the company 2022/2023 of the first quarter. Carl Zeiss Meditec expects growth for the full fiscal year to be at least in line with market growth. „Inflationary pressures on materials, logistics and personnel and bottlenecks in the supply chain remain. At the same time, investments in sales and marketing activities and research and product development will remain at a high level as planned behind the introduction of new products and innovations,” the company also announced . The profit margin before interest and taxes should fall – Carl Zeiss Meditec (WKN: 531370, ISIN: DE000531370 , Chart) expects a value of 19-21 percent.